Search      Advanced Search | Browse By Topic
Magazine Content
Home
Features
Columnists
Industry Risk Reports
In-Depth Series
Special Reports
Point/Counterpoint
R&I One® Content
News & Analysis
Editor's Choice Stories
Resources and Tools
Power Broker® Directory
Risk InnovatorTM
Emerging Risks
Top Employee Benefits Consultant
Executives To Watch
Insights
Industry Events
WorkersComp Forum
Award Nominations
Webinars
RSS
R&I Information
Subscription Center
Advertiser Information
About Us
Contact Us
 

Newsletter Sign-up

Click on the name of the free newsletter below to preview:

R&I One®
WORKERSCOMP Forum TM Update
HTML Text
E-Mail Address:


Click here to unsubscribe
Privacy Policy
Preferences

 

NCOIL 'developing game plan' as Florida proponents ponder inaction

A model law for states to address high-priced repackaged drugs being sold from physicians' offices may be forthcoming.

Print Email Add to Facebook Add to Twitter Add to LinkedIn Write to the Editor Reprints

The National Conference of Insurance Legislators' workers' compensation insurance committee is comparing state repackaged drug requirements and "may consider a proposed model law based on one or more approaches," a spokeswoman said.

"Legislators have laid a foundation for regulating controversial physician sales of repackaged drugs" in an effort to prevent spiraling workers' comp costs, the conference said. "The Workers' Compensation Insurance Committee is responding to concerns that allegedly overpriced repackaged drugs, which are dispensed by doctors in their offices rather than through pharmacies, lead to higher medical costs and, therefore, insurance premiums."

The committee heard from several stakeholders during the recent NCOIL spring meeting. Representatives of the insurance industry and a health care provider were on hand, along with someone from NCCI.

The rate-making organization said that "repackaged drug sales are escalating, especially in regions such as the South and Midwest." Insurer representatives supported the idea of amending pharmaceutical fees schedules so the average wholesale price is no more than what a non-repackaged drug would cost. It also noted that Massachusetts, New York, and Texas prohibit repackaging.

Committee members will regroup and determine their next steps at the NCOIL summer meeting in July.

Florida takes no action. A well-publicized effort to cut workers' comp reimbursements to physicians who dispense medications failed to pass in the Florida Legislature. S.B. 668 would have banned doctors who dispense repackaged drugs to workers' comp patients from charging more than pharmacies.

The measure had the backing of several business and insurance organizations, including the Florida Chamber of Commerce. The group said passage of the bill would have saved businesses more than $60 million.

Opponents of the bill said dispensing drugs from physician's offices rather than writing prescriptions is a better way to ensure patients will take the medications.

This was the third effort to curtail physician reimbursements for repackaged drugs. Three years ago former Gov. Charlie Crist vetoed a cap that had been unanimously passed in both chambers.

Read more at the WorkersComp Forum homepage.

April 5, 2012

Copyright 2012© LRP Publications

 
 
 
 
 
 
 
 
 
 
 
RISK logo
 

Back to top

Entire contents copyright © 2013 Risk and Insurance® All rights reserved. May not be reproduced in any form without written permission.